PROXIMATE-TIMI 27 evaluated the safety and hemostatic effects of a monoclonal antibody to tissue factor in patients with stable coronary disease. MAIN RESULTS: Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial Eur Heart J. 2005 Apr;26(7):682-8. PRESENTATIONS TIMI 27 Slides